ConductScience.org, home

Paper40970519

The potential of phytomedicines to optimize CAR-T cell therapy in cancer.

Covo-Vergara Á and 8 others. Immunotherapy, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. The potential of phytomedicines to optimize CAR-T cell therapy in cancer. Papers, record 40970519. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40970519

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The potential of phytomedicines to optimize CAR-T cell therapy in cancer.
PubMed
Journal
Immunotherapy
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Covo-Vergara ÁÁngela
2De Ulzurrun-Ripa UDUxue Díez
3Smerdou CCristian
4Hernández-Rueda MMercedes
5Estrada-Palafox DGDelia G
6Ureña CClaudia
7Hervas-Stubbs SSandra
8Fiorentino SSusana
9Garcia-Garcia MRMaritza R

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunotherapy, AdoptiveMajor topic
NeoplasmsMajor topic
Receptors, Chimeric AntigenMajor topic
PhytochemicalsMajor topic
T-LymphocytesMajor topic
Humans
Tumor Microenvironment
Animals
Adjuvants, Immunologic

Source PubMed

Download CSV of topics

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137047272CAR T Cell Therapy: A Versatile Living Drug.Int J Mol Sci2023https://conductscience.org/library/papers/37047272PubMed
237834228Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Systematic Review.Int J Mol Sci2023https://conductscience.org/library/papers/37834228PubMed
337657771The Qi Yin San Liang San decoction enhances anti-CD19 CAR-T cell function in the treatment of B-cell lymphomas.J Ethnopharmacol2024https://conductscience.org/library/papers/37657771PubMed
436160152Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et).Front Med (Lausanne)2022https://conductscience.org/library/papers/36160152PubMed
532433532A guide to cancer immunotherapy: from T cell basic science to clinical practice.Nat Rev Immunol2020https://conductscience.org/library/papers/32433532PubMed
622594470Pro-oxidant natural products as anticancer agents.Curr Drug Targets2012https://conductscience.org/library/papers/22594470PubMed
737696152Influence of the crystallinity on the physicochemical properties of spray-dried quercetin-inulin microparticles and their performance during in vitro digestion.Food Chem2024https://conductscience.org/library/papers/37696152PubMed
834751930Advances in plant-derived natural products for antitumor immunotherapy.Arch Pharm Res2021https://conductscience.org/library/papers/34751930PubMed
912553376Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice.Clin Exp Metastasis2002https://conductscience.org/library/papers/12553376PubMed
1019017389Petiveria alliacea extracts uses multiple mechanisms to inhibit growth of human and mouse tumoral cells.BMC Complement Altern Med2008https://conductscience.org/library/papers/19017389PubMed
1132354172Organic Acids from Roselle (Hibiscus sabdariffa L.)-A Brief Review of Its Pharmacological Effects.Biomedicines2020https://conductscience.org/library/papers/32354172PubMed
1237670337Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC).BMC Complement Med Ther2023https://conductscience.org/library/papers/37670337PubMed
1332878978Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors.Sci Transl Med2020https://conductscience.org/library/papers/32878978PubMed
1435814023Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/35814023PubMed
1529497610Cancer Chemoprevention and Piperine: Molecular Mechanisms and Therapeutic Opportunities.Front Cell Dev Biol2018https://conductscience.org/library/papers/29497610PubMed
1633312174An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma.Front Immunol2020https://conductscience.org/library/papers/33312174PubMed
1734568831Scalable Manufacturing of CAR T cells for Cancer Immunotherapy.Blood Cancer Discov2021https://conductscience.org/library/papers/34568831PubMed
1833552924Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from Caesalpinia spinosa.Toxicol Rep2021https://conductscience.org/library/papers/33552924PubMed
1937413990Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity.Cell2023https://conductscience.org/library/papers/37413990PubMed
2036358624Role of Immunotherapy in the Treatment of Cancer: A Systematic Review.Cancers (Basel)2022https://conductscience.org/library/papers/36358624PubMed

See all 79 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40970519

GET https://conductscience.org/api/papers/v1/40970519/references?page=2